Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer and other serious diseases. Genmab’s proprietary pipeline includes bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. Visit us at Genmab.com or Twitter.com/Genmab.